Frontlight ResearchEarly access
Trial site
NDx Clinical Research Inc.
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Multiple sclerosis1 trial
- Phase
- Phase 33 trials
- Phase 2/31 trial
- Status
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- ACADIA Pharmaceuticals Inc.1 trial
- Amgen1 trial
- Bristol-Myers Squibb1 trial
- Eli Lilly and Company1 trial
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026